- $4.46bn
- $5.06bn
- $2.31bn
- 80
- 28
- 86
- 70
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,737 | 1,936 | 2,036 | 2,243 | 2,308 |
Cost of Revenue | |||||
Gross Profit | 332 | 382 | 366 | 423 | 444 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 1,584 | 1,784 | 1,929 | 1,894 | 2,091 |
Operating Profit | 153 | 152 | 107 | 349 | 217 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 147 | 138 | 83.6 | 316 | 196 |
Provision for Income Taxes | |||||
Net Income After Taxes | 113 | 107 | 69.6 | 246 | 159 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 113 | 107 | 69.6 | 246 | 159 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 112 | 106 | 69.2 | 245 | 159 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.32 | 2.29 | 1.47 | 2.16 | 2.83 |
Dividends per Share |